Thus, APS1 sera appeared to react against either CYP17 or CYPscc, while CYP21 was thought to represent an exclusive target of autoimmunity in sporadic and APS2-associated AAD (281, 282). The gene discussed is CYP21A2; the disease is autoimmune polyendocrine syndrome type 1.